DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)

CNY 16.16

(0.56%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 24.12 Billion 20.84 Billion 17.33 Billion 12.33 Billion 8.67 Billion 6.53 Billion
Total Current Assets 10.79 Billion 10.66 Billion 7.86 Billion 8.29 Billion 5.46 Billion 4.02 Billion
Cash And Short Term Investments 4.45 Billion 4.58 Billion 2.9 Billion 4.44 Billion 1.71 Billion 1.32 Billion
Cash and Cash Equivalents 4.41 Billion 4.49 Billion 2.79 Billion 3.75 Billion 1.71 Billion 1.32 Billion
Short Term Investments 41.98 Million 91.98 Million 109.37 Million 689.97 Million -458.83 Million -443.32 Million
Net Receivables 1.86 Billion 2.01 Billion 1.19 Billion 755.79 Million 655.01 Million 599.97 Million
Inventory 4.18 Billion 3.87 Billion 3.63 Billion 2.68 Billion 2.05 Billion 1.88 Billion
Other Current Assets 291.6 Million 201.37 Million 138.3 Million 418.63 Million 1.04 Billion 210.15 Million
Total Non-Current Assets 13.32 Billion 10.17 Billion 9.46 Billion 4.03 Billion 3.2 Billion 2.51 Billion
Net PPE 7.34 Billion 6.09 Billion 5.65 Billion 1.28 Billion 1.11 Billion 983.18 Million
Good Will And Intangible Assets 4.9 Billion 3.06 Billion 2.73 Billion 1.87 Billion 1.36 Billion 821.67 Million
Good Will 3.02 Billion 2.36 Billion 2.05 Billion 1.33 Billion 983.72 Million 534.04 Million
Intangible Assets 1.88 Billion 700.55 Million 676.41 Million 538.52 Million 384.82 Million 287.62 Million
Long-Term Investments 155.58 Million 40.17 Million 40.79 Million -539.67 Million 575.78 Million 587.21 Million
Tax Assets 214.48 Million 186.3 Million 157.57 Million 41.52 Million 38.37 Million 23 Million
Other Non Current Assets 708.34 Million 785.84 Million 879.5 Million 1.37 Billion 102.03 Million 96.79 Million
Other Assets 0.00 1.00 1.00 - - 1.00
Total Liabilities 16.17 Billion 13.97 Billion 11.39 Billion 6.75 Billion 4.34 Billion 3.45 Billion
Total Current Liabilities 11.45 Billion 9.7 Billion 7.17 Billion 5.46 Billion 4 Billion 3.41 Billion
Account Payables 2.74 Billion 6.12 Billion 4.73 Billion 4.21 Billion 3.19 Billion 2.54 Billion
Tax Payables 176.2 Million 244.17 Million 166.56 Million 193.06 Million 125.98 Million 121.54 Million
Short Term Debt 5.95 Billion 1.67 Billion 1.07 Billion 191.9 Million 68.84 Million 331.38 Million
Deferred Revenue 362.4 Million 435.72 Million 1.34 Billion 1.05 Billion 689.47 Million 121.54 Million
Other Current Liabilities 2.38 Billion 1.46 Billion 18.59 Million 5.75 Million 44.9 Million 411.6 Million
Total Non Current Liabilities 4.71 Billion 4.26 Billion 4.22 Billion 1.29 Billion 337.38 Million 36.2 Million
Long-Term Debt 1.64 Billion 4.25 Billion 4.2 Billion 1.2 Billion 260.44 Million 21.44 Million
Deferred Revenue Non Current 19.29 Million 17.64 Million 20.12 Million 83.27 Million 76.93 Million 14.75 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 4.3 Million 327.53 Thousand -1.25 Billion - 260.44 Million 21.44 Million
Other Liabilities 1.00 1.00 1.00 1.00 1.00 -
Total Equity 7.93 Billion 6.86 Billion 5.93 Billion 5.57 Billion 4.33 Billion 3.08 Billion
Stock Holders Equity 6.82 Billion 6.21 Billion 5.47 Billion 5.38 Billion 4.23 Billion 3.03 Billion
Common Stock 1.13 Billion 949.11 Million 790.93 Million 658.62 Million 539.54 Million 400.01 Million
Retained Earnings 3.68 Billion 3.18 Billion 2.6 Billion 2.62 Billion 1.96 Billion 1.54 Billion
Accumulated other comprehensive income 672.98 Million 707.4 Million 565.41 Million 392.4 Million 258 Million 159.27 Million
Common Stock Equity 6.82 Billion 6.21 Billion 5.47 Billion 5.38 Billion 4.23 Billion 3.03 Billion
Capital Lease Obligation 3.07 Billion 2.79 Billion 2.95 Billion 2.57 Billion - -
Total Investments 197.57 Million 132.15 Million 150.16 Million 150.3 Million 116.95 Million 143.88 Million
Total Debt 10.66 Billion 5.93 Billion 5.27 Billion 1.39 Billion 329.28 Million 352.82 Million
Net Debt 6.25 Billion 1.43 Billion 2.48 Billion -2.35 Billion -1.38 Billion -976.18 Million

Balance Sheet Charts